Ocular Therapeutix (OCUL) is a Strong Buy, driven by the pivotal SOL-1 Phase 3 trial for AXPAXLI™ in wet AMD, with topline ...
BOSTON, MA, UNITED STATES, January 8, 2026 /EINPresswire.com/ -- EyeCool Therapeutics, a clinical-stage ophthalmic ...
Fundus photography involves taking a photo of the back of the eye to detect signs of diabetic retinopathy. It is also possible to capture an image of the retina using a smartphone. Diabetic ...
Background Both host and microbe metabolism of tryptophan (Trp) is altered in diabetes; however, the molecular mechanisms are incompletely understood. Objective We used strategies to increase either ...
Investor's Business Daily on MSN
Ocular Launches, And Then Yo-Yoes, On Rumors Sanofi Is Preparing A Bigger Bid
Shares of Ocular Therapeutix launched and then yo-yoed Thursday on reports Sanofi is preparing an improved bid to buy it.
Ocular Therapeutix, Inc. (NASDAQ: OCUL, “Ocular”), an integrated biopharmaceutical company committed to redefining the retina experience, today announced that it has granted inducement awards to its ...
Understanding how pregnancy may yield ocular changes will help ophthalmologists put together an effective treatment plan, ...
Patients with double seronegative myasthenia gravis (dSNMG) had similar clinical characteristics across the board, according to a review published in BMC Neurology. 1 Ocular symptoms and malignancy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results